Outcomes | Unadjusted | Adjusted** |
---|
RR* | 95% CI | RR* | 95% CI |
---|
Retention at 6-monthsa | 0.92 | (0.87, 0.97) | 0.89 | (0.87, 0.90) |
Retention at 12-monthsb | 0.92 | (0.86, 0.99) | 0.86 | (0.83, 0.89) |
LTFU at 6-monthsc | 2.45 | (1.64, 3.66) | 2.92 | (1.57, 5.42) |
LTFU at 12-monthsd | 1.80 | (1.33, 2.43) | 2.11 | (1.70, 2.61) |
Mortality at 6-monthse | 0.74 | (0.40, 1.38) | 1.26 | (0.93, 1.71) |
Mortality at 12-monthsf | 0.61 | (0.35, 1.05) | 0.94 | (0.63, 1.40) |
- LTFU Loss to follow-up, RR risk ratio
- *Reference group = persons initiated on ART > 7 days after HIV diagnosis
- **Multivariable logistic regression model included the propensity score and other covariates such as:
- aage, BMI, CPT, IPT, baseline OI, baseline functional status and partner’s HIV status
- bage, gender, BMI, IPT, baseline OI, baseline functional status, baseline WHO clinical stage, and partner’s HIV status
- cage, gender, education status, CPT, IPT, baseline OI and partner’s HIV status
- dage, gender, IPT, baseline OI, baseline WHO clinical stage and partner’s HIV status
- eage, educational status, BMI, baseline OI and baseline WHO clinical stage
- fage, educational status, BMI, CPT, IPT and baseline functional status